The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 6, Pages 838
Publisher
MDPI AG
Online
2019-06-17
DOI
10.3390/cancers11060838
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epithelial‑mesenchymal transition induced by bone morphogenetic protein 9 hinders cisplatin efficacy in ovarian cancer cells
- (2019) Ying Wang et al. Molecular Medicine Reports
- Combinatorial therapy of immune checkpoint and cancer pathways provides a novel perspective on ovarian cancer treatment (Review)
- (2019) Guyu Zhang et al. Oncology Letters
- Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers
- (2019) Paweł Sadłecki et al. Journal of Ovarian Research
- SMAD3 inducing the transcription of STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel
- (2019) Yangyang Shi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities
- (2019) San-Nung Chen et al. International Journal of Environmental Research and Public Health
- Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition
- (2019) Lei Zhang et al. Frontiers in Immunology
- Regulation of epithelial to mesenchymal transition by BRCA1 in breast cancer
- (2018) Satheesh Kumar Sengodan et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells
- (2018) Rahul Bhattacharya et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer
- (2018) Sophia A. Shahin et al. Nanomedicine-Nanotechnology Biology and Medicine
- Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer
- (2018) Sara Al Habyan et al. ONCOGENE
- CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway
- (2018) Linlin Wang et al. ONCOLOGY REPORTS
- Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma
- (2018) Nirmala Jagadish et al. TUMOR BIOLOGY
- Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers
- (2018) Pawel Sadlecki et al. TUMOR BIOLOGY
- Role of tumor microenvironment in ovarian cancer pathobiology
- (2018) Alia Ghoneum et al. Oncotarget
- Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)
- (2018) Young Kwang Chae et al. Scientific Reports
- Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer
- (2018) N. Hojo et al. Scientific Reports
- CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
- (2018) Michela Lupia et al. Stem Cell Reports
- MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R
- (2018) Yong Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- STAT3 regulatedmiR-216apromotes ovarian cancer proliferation and cisplatin resistance
- (2018) Pengfei Jin et al. BIOSCIENCE REPORTS
- Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation
- (2018) Meng Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Identification of the tumour transition states occurring during EMT
- (2018) Ievgenia Pastushenko et al. NATURE
- Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis
- (2018) Li Sun et al. Cell Death & Disease
- Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition
- (2018) Ling Qiu et al. Scientific Reports
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer of the ovary, fallopian tube, and peritoneum
- (2018) Jonathan S. Berek et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Non-redundant functions of EMT transcription factors
- (2018) Marc P. Stemmler et al. NATURE CELL BIOLOGY
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer
- (2018) Xin Wu et al. Cell Death & Disease
- CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression
- (2018) Ying Xu et al. Cancer Medicine
- Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models
- (2018) Daniel Newsted et al. OncoImmunology
- IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
- (2018) Landon Browning et al. Cancer Management and Research
- SIRT6 Is Involved in the Progression of Ovarian Carcinomas via β-Catenin-Mediated Epithelial to Mesenchymal Transition
- (2018) Jun Sang Bae et al. Frontiers in Oncology
- Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer
- (2017) Marta De Donato et al. GYNECOLOGIC ONCOLOGY
- miRNAs and ovarian cancer: An overview
- (2017) Bornali Deb et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination
- (2017) Agnès Figueras et al. MOLECULAR CANCER THERAPEUTICS
- KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance
- (2017) Tongfu Feng et al. Molecular Medicine Reports
- Adipose-derived mesenchymal stem cells attenuate cisplatin-induced apoptosis in epithelial ovarian cancer cells
- (2017) Yiping Wen et al. Molecular Medicine Reports
- Context-specific roles of EMT programmes in cancer cell dissemination
- (2017) M. Angela Nieto NATURE CELL BIOLOGY
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- TLR5/7-mediated PI3K activation triggers epithelial-mesenchymal transition of ovarian cancer cells through WAVE3-dependent mesothelin or OCT4/SOX2 expression
- (2017) Ga Bin Park et al. ONCOLOGY REPORTS
- E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness
- (2017) Marina Rosso et al. PLoS One
- Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
- (2017) Brian Bierie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stress-Activated Chaperones: A First Line of Defense
- (2017) Wilhelm Voth et al. TRENDS IN BIOCHEMICAL SCIENCES
- MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line
- (2017) Yankun Liu et al. Oncology Letters
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers
- (2017) Natasa Kenda Suster et al. Journal of Ovarian Research
- Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition
- (2017) Shan Deng et al. Oncotarget
- Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells
- (2017) Jun Sakata et al. Oncotarget
- PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state
- (2017) Kholoud Alwosaibai et al. Oncotarget
- NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells
- (2017) Ya Zhou et al. Oncotarget
- Revisiting ovarian cancer microenvironment: a friend or a foe?
- (2017) Boyi Zhang et al. Protein & Cell
- miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway
- (2017) S-L Tung et al. Oncogenesis
- Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination
- (2017) Yuliya Klymenko et al. NEOPLASIA
- Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer
- (2017) Yuliya Klymenko et al. Cancers
- Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling
- (2017) Chantel Samardzija et al. Scientific Reports
- Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells
- (2017) Maura Sonego et al. Scientific Reports
- The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications
- (2016) Ivo Meinhold-Heerlein et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- The relationship between platinum drug resistance and epithelial–mesenchymal transition
- (2016) Anamaria Brozovic ARCHIVES OF TOXICOLOGY
- EMT, cell plasticity and metastasis
- (2016) Christine L. Chaffer et al. CANCER AND METASTASIS REVIEWS
- Stress Chaperone Mortalin Contributes to Epithelial-to-Mesenchymal Transition and Cancer Metastasis
- (2016) Y. Na et al. CANCER RESEARCH
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo
- (2016) Chanjuan Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
- (2016) Y. Lou et al. CLINICAL CANCER RESEARCH
- Targeting the tumour microenvironment in ovarian cancer
- (2016) Jean M. Hansen et al. EUROPEAN JOURNAL OF CANCER
- Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance
- (2016) Bernadette M. Boac et al. GYNECOLOGIC ONCOLOGY
- Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
- (2016) Veronica Rojas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epithelial-to-Mesenchymal Transition in Paclitaxel-Resistant Ovarian Cancer Cells Is Downregulated by Luteolin
- (2016) Vermont P Dia et al. JOURNAL OF CELLULAR PHYSIOLOGY
- BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells
- (2016) Hua Wang et al. MOLECULAR CELL
- TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial–mesenchymal transition
- (2016) Maria R Amoroso et al. Cell Death & Disease
- Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
- (2016) Chi Lam Au Yeung et al. Nature Communications
- HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation
- (2016) Suresh Bugide et al. CELLULAR ONCOLOGY
- Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop
- (2016) Lan G. Coffman et al. Oncotarget
- BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions
- (2016) Abhilasha Sinha et al. Oncotarget
- Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy
- (2016) Francesca Ricci et al. Oncotarget
- Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
- (2016) Shailendra Kumar Dhar Dwivedi et al. Oncotarget
- Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors
- (2016) Winyoo Chowanadisai et al. PLoS One
- Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
- (2016) Carman K. M. Ip et al. Scientific Reports
- Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
- (2015) Joan L. Walker et al. CANCER
- TGFβ signaling regulates epithelial–mesenchymal plasticity in ovarian cancer ascites-derived spheroids
- (2015) Samah Rafehi et al. ENDOCRINE-RELATED CANCER
- Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
- (2015) Guoyan Liu et al. JNCI-Journal of the National Cancer Institute
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
- (2015) Claudia Allemani et al. LANCET
- Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
- (2015) Abdullah Alsuliman et al. Molecular Cancer
- The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells
- (2015) Anamaria Brozovic et al. Molecular Oncology
- miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
- (2015) X Zhu et al. ONCOGENE
- Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma
- (2015) Changmei Liu et al. TUMOR BIOLOGY
- Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
- (2015) Guoyan Liu et al. JNCI-Journal of the National Cancer Institute
- Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells
- (2015) Michaela L. Granados et al. PLoS One
- FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
- (2015) Wen-Tai Chiu et al. Oncotarget
- Liposomal siRNA nanocarriers for cancer therapy
- (2014) Bulent Ozpolat et al. ADVANCED DRUG DELIVERY REVIEWS
- The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer
- (2014) F. Zeppernick et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
- (2014) Sunila Pradeep et al. CANCER CELL
- Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
- (2014) Francois Moisan et al. Molecular Oncology
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
- (2014) Q H Miow et al. ONCOGENE
- Resveratrol Inhibits Cisplatin-Induced Epithelial-to-Mesenchymal Transition in Ovarian Cancer Cell Lines
- (2014) Sébastien Baribeau et al. PLoS One
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer
- (2013) Madhuri Koti et al. BMC CANCER
- Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer
- (2013) W.J. Sheng et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- Inhibition of mortalin expression reverses cisplatin resistance and attenuates growth of ovarian cancer cells
- (2013) Ling Yang et al. CANCER LETTERS
- Epithelial-to-Mesenchymal Transition and Autophagy Induction in Breast Carcinoma Promote Escape from T-cell-Mediated Lysis
- (2013) I. Akalay et al. CANCER RESEARCH
- Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
- (2013) Tuan Zea Tan et al. EMBO Molecular Medicine
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- Mechanisms that link the oncogenic epithelial–mesenchymal transition to suppression of anoikis
- (2013) Steven M. Frisch et al. JOURNAL OF CELL SCIENCE
- Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
- (2013) Khalid Abubaker et al. Molecular Cancer
- Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules
- (2013) I. Rizvi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
- (2013) R Y-J Huang et al. Cell Death & Disease
- Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decade
- (2012) Willi Oberaigner et al. ACTA ONCOLOGICA
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1
- (2012) Oscar H. Ocaña et al. CANCER CELL
- TGF- -induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion
- (2012) S. Lamouille et al. JOURNAL OF CELL SCIENCE
- Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium
- (2012) Stefanie Aust et al. Molecular Cancer
- c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling
- (2012) W K Chau et al. ONCOGENE
- Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN
- (2012) Mingli Han et al. PLoS One
- Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7BThis paper is one of a selection of papers published in a Special Issue entitled CSBMCB 53rd Annual Meeting — Membrane Proteins in Health and Disease, and has undergone the Journal’s usual peer review process.
- (2011) Oleg Y. Dmitriev Biochemistry and Cell Biology
- Cancer Stem Cell Niche: The Place to Be
- (2011) T. Borovski et al. CANCER RESEARCH
- Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells
- (2011) L. Rosano et al. CLINICAL CANCER RESEARCH
- Overcoming anoikis - pathways to anchorage-independent growth in cancer
- (2011) M. C. Guadamillas et al. JOURNAL OF CELL SCIENCE
- Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile
- (2011) Ardian Latifi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA-200c Represses Migration and Invasion of Breast Cancer Cells by Targeting Actin-Regulatory Proteins FHOD1 and PPM1F
- (2011) S. Jurmeister et al. MOLECULAR AND CELLULAR BIOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Correction: Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
- (2011) Robert Strauss et al. PLoS One
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin
- (2010) J-C Cheng et al. ONCOGENE
- ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1
- (2010) E Sánchez-Tilló et al. ONCOGENE
- Targeting the Mechanisms of Resistance to Chemotherapy and Radiotherapy with the Cancer Stem Cell Hypothesis
- (2010) Ryan Morrison et al. Journal of Oncology
- Ovarian Low-grade and High-grade Serous Carcinoma
- (2009) Russell Vang et al. ADVANCES IN ANATOMIC PATHOLOGY
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Pathogenesis of Ovarian Cancer
- (2009) Robert J. Kurman et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- BRCA1 and its toolbox for the maintenance of genome integrity
- (2009) Michael S.Y. Huen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
- (2009) N J Sullivan et al. ONCOGENE
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
- (2009) Dawn R. Cochrane et al. Journal of Oncology
- Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via 5-Integrin, which Is a Therapeutic Target
- (2008) K. Sawada et al. CANCER RESEARCH
- Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression
- (2008) Laurie G. Hudson et al. CLINICAL & EXPERIMENTAL METASTASIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now